Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Medarex Paying $4.7M To Acquire Ability Biomedical

June 28, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Generex Receiving $30M Via Sejong Oralin Licensing Deal

June 25, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Kosan, Roche Stop Colorectal Cancer Trial, Shift To Prostate

June 24, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

Taste Technology Firm Senomyx Goes Public With $36M Offering

June 23, 2004

By Aaron Lorenzo

Merix, Kirin Collaborating For Personalized Vaccine Products

June 23, 2004

By Aaron Lorenzo

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...